1. Home
  2. IGC vs NTIP Comparison

IGC vs NTIP Comparison

Compare IGC & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • NTIP
  • Stock Information
  • Founded
  • IGC 2005
  • NTIP 1990
  • Country
  • IGC United States
  • NTIP United States
  • Employees
  • IGC N/A
  • NTIP N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • NTIP Multi-Sector Companies
  • Sector
  • IGC Health Care
  • NTIP Miscellaneous
  • Exchange
  • IGC Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • IGC 33.5M
  • NTIP 28.6M
  • IPO Year
  • IGC N/A
  • NTIP 1998
  • Fundamental
  • Price
  • IGC $0.37
  • NTIP $1.40
  • Analyst Decision
  • IGC Strong Buy
  • NTIP
  • Analyst Count
  • IGC 2
  • NTIP 0
  • Target Price
  • IGC $3.88
  • NTIP N/A
  • AVG Volume (30 Days)
  • IGC 7.5M
  • NTIP 41.6K
  • Earning Date
  • IGC 08-07-2025
  • NTIP 08-11-2025
  • Dividend Yield
  • IGC N/A
  • NTIP 7.14%
  • EPS Growth
  • IGC N/A
  • NTIP N/A
  • EPS
  • IGC N/A
  • NTIP N/A
  • Revenue
  • IGC $1,271,000.00
  • NTIP $250,000.00
  • Revenue This Year
  • IGC $15.26
  • NTIP N/A
  • Revenue Next Year
  • IGC $3.41
  • NTIP N/A
  • P/E Ratio
  • IGC N/A
  • NTIP N/A
  • Revenue Growth
  • IGC N/A
  • NTIP N/A
  • 52 Week Low
  • IGC $0.25
  • NTIP $1.16
  • 52 Week High
  • IGC $0.48
  • NTIP $1.78
  • Technical
  • Relative Strength Index (RSI)
  • IGC 54.60
  • NTIP 61.33
  • Support Level
  • IGC $0.30
  • NTIP $1.38
  • Resistance Level
  • IGC $0.46
  • NTIP $1.46
  • Average True Range (ATR)
  • IGC 0.04
  • NTIP 0.06
  • MACD
  • IGC 0.00
  • NTIP 0.01
  • Stochastic Oscillator
  • IGC 33.00
  • NTIP 76.92

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: